Touyun Biotech Group Reports Turnaround in Interim Results
I'm PortAI, I can summarize articles.
Touyun Biotech Group Limited reported a significant turnaround in its interim results for the six months ending June 30, 2025, achieving a profit of HK$28.05 million, compared to a loss of HK$48.82 million in the same period of 2024. This improvement was attributed to gains in other income and reduced losses from discontinued operations. The company, listed on the Hong Kong Stock Exchange under stock code 1332, operates in the biotechnology sector, focusing on treasury investment and money lending.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments